Page 280 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Viral Hepatitis: Hepatitis C - Clinical (New Compounds, Resistance) (Cont.)

YI P0915 CLINICAL RELEVANCE OF BASELINE/EARLY DETECTION
AND PERSISTENCE OF RESISTANT ASSOCIATED
VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE-
INHIBITORS ASSESSED BY ULTRA-DEEP SEQUENCING
Velia Chiara Di Maio*, Daniele Armenia, Maria Concetta Bellocchi,
Daniele Di Paolo, Valeria Cento, Monica Tontodonati, Valeria Micheli,
Luca Carioti, Francesco De Leonardis, Marianna Aragri, Ennio Polilli,
Alessandra Manunta, Carlo Magni, Francesco Paolo Antonucci,
Francesca De Luca, Cesare Sarrecchia, Ada Bertoli, Ilaria Lenci,
Simona Francioso, Maria Mercedes Santoro, Jacopo Vecchiet,
Andrea De Maria, Antonino Picciotto, Lorenzo Nosotti,
Filomena Morisco, Savino Bruno, Massimo Puoti, Sergio Babudieri,
Maria Stella Mura, Gloria Taliani, Massimo Andreoni,
Giuliano Rizzardini, Giustino Parruti, Mario Angelico,
Carlo Federico Perno, Francesca Ceccherini-Silberstein, Italy

YI P0916 EMERGENCE OF HEPATITIS C VIRUS GENOTYPE
RECOMBINANT FORMS 2K/1B IN GEORGIA
ePOSTERS Mamuka Zakalashvili, Michael Weizenegger, J. Bartel, M. Markowski,
T. Telia, T. Dzagania, J. Zarqua, L. Zangurashvili, N. Kankia,
N. Jashiashvili, M. Lomidze, V. Kerashvili, M. Zhamutashvili,
N. Abramishvili, David Metreveli*, I. Rtskhiladze, Georgia

P1352 PHARMACOKINETICS AND PHARMACOLOGY OF RG-101,
A NOVEL GALNAC-CONJUGATED OLIGONUCLEOTIDE
TARGETING MICRORNA-122, IN HEALTHY VOLUNTEERS
Kai Liu, Steven Neben, Neil W. Gibson*, Paul Grint, Andre van Vliet,
Salah Hadi, Marleen de Vree, Meike van der Ree, Henk Reesink,
The United States

280 The International Liver Congress™ 2015 • ILC Programme